Download Files:
Enavogliflozin
$480 – $2,200
Products Details
Product Description
– Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3].
Web ID
– HY-109144
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C24H27ClO6
References
– [1]Daewoong speeds up developing antidiabetic Enavogliflozin|[2]These are the results of clinical trials of the diabetes drug Enavogliflozin and Metformin|[3]Global Diabetes Pipeline Landscape Report 2020 Featuring Daewoong’s Enavogliflozin & Janssen Biotech’s Golimumab Among Others – ResearchAndMarkets.com
CAS Number
– 1415472-28-4
Molecular Weight
– 446.92
Compound Purity
– 98.01
SMILES
– O[C@H]([C@H]1O)[C@@H](O[C@H](CO)[C@H]1O)C2=C(CCO3)C3=C(Cl)C(CC4=CC=C(C5CC5)C=C4)=C2
Clinical Information
– Phase 4
Research Area
– Metabolic Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– SGLT
Isoform
– SGLT2
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
